Publication: 3722

Publication: 3722

Prognostic and predictive implications of the intrinsic subtypes and gene expression signatures in early-stage HER2+ breast cancer: a pooled analysis of CALGB 40601 (Alliance), NeoALTTO and NSABP B-41 trials

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 40 (16_suppl) 509-509

Meeting Instance:: ASCO 2022
Year:: 2022
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 4006

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: GSK/Novartis
Grants:: U10CA180821, U24CA196171, P50-CA58823, R01-CA229409, P30CA051008

Corr. Author:
Authors:: Aranzazu Fernandez-Martinez Mattia Rediti Gong Tang Tomás Pascual Katherine A. Hoadley David Venet Naim U. Rashid Patricia A. Spears Md N. Islam David Goerlitz Rong Hu Peter Lucas Sandra M. Swain Christos Sotiriou Charles M. Perou Lisa A. Carey

Networks:: CAPITAL, LAPS-NC007, ME040

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-40601, NeoALTTO, NSABP B-41
Phases:: 3

Keywords: